If you’re scoping AI governance engagements for regulated clients, the first thing to accept is that a generic framework won’t get you through the door. AI governance financial services clients face model risk management requirements that healthcare clients never see. Healthcare clients carry HIPAA obligations that defense contractors don’t. And defense industrial base (DIB) clients operate under export controls and supply-chain security requirements that would be irrelevant in a hospital system. The sector shapes the obligation — and the MSP that understands that distinction before the first discovery call is the one that wins the engagement. This post maps the specific AI governance requirements across all three verticals and shows how to build a service structure that handles them without rebuilding your delivery model from scratch for every client.
Why Vertical-Specific AI Governance Rules Apply to MSP Clients
Generic AI governance frameworks — ISO 42001, NIST AI RMF, even the EU AI Act — provide a useful governance skeleton. But they are not compliance programs. They don’t satisfy SR 11-7 for a bank. They don’t satisfy HIPAA’s minimum necessary standard for a health system. They don’t satisfy CMMC Level 2 for a defense subcontractor. Regulated clients operate under sector-specific obligations that sit on top of any horizontal framework, and those obligations translate directly into MSP deliverables. Managed service provider AI governance engagements in regulated industries require you to know the sector’s specific regulatory obligations, not just the horizontal frameworks. You need to know which controls are mandatory versus advisory, which regulators have enforcement authority, and what documentation your client needs to produce during an examination or audit. That knowledge is what separates a governance advisory engagement from a compliance delivery engagement — and the latter commands significantly higher fees. AI governance data privacy obligations also vary by sector. Financial services clients may be subject to GLBA, GDPR (for EU data subjects), and state-level privacy laws simultaneously. Healthcare clients face HIPAA’s specific requirements around protected health information (PHI). Defense clients face ITAR and EAR restrictions that treat certain AI model outputs as controlled technical data. Understanding which privacy regime governs AI governance customer data in each context is foundational to scoping the engagement correctly. For a full treatment of the framework layer that sits beneath all of this, see AI Governance for Managed Service Providers: The Complete Framework Guide.
AI Governance in Financial Services: Regulatory Obligations and MSP Responsibilities
AI governance financial services requirements are more mature and more prescriptive than in most other sectors. The Federal Reserve’s SR 11-7 guidance on model risk management has been the de facto standard for model governance at US banks since 2011, and regulators have consistently applied it to AI and machine learning models. The OCC, FDIC, and CFPB have each issued guidance reinforcing the expectation that financial institutions maintain documented model inventories, validation processes, and ongoing performance monitoring. For MSPs, this translates into a specific set of deliverables:
- Model inventory and classification. Clients need a complete, current inventory of AI models in production, with risk tiering based on materiality and complexity. The MSP’s role is often to build and maintain this inventory as a managed service, not just advise on its structure.
- Explainability and adverse action documentation. Models used in credit decisions, fraud detection, or customer risk scoring must produce outputs that can be explained to regulators and, in consumer-facing contexts, to customers. ECOA and FCRA requirements around adverse action notices apply to algorithmic decisions. AI governance data privacy obligations under GDPR’s Article 22 add a right-not-to-be-subject-to-automated-decision-making layer for EU data subjects.
- Audit trails. Regulators expect to see evidence of model validation, change management, and ongoing monitoring. MSPs that can deliver structured audit trail documentation — not just logs, but governed records — are providing something clients genuinely struggle to produce internally.
- AI governance GDPR compliance is a live concern for any financial services client processing EU data. The GDPR’s requirements around automated decision-making, data minimization, and purpose limitation apply directly to AI systems, and the EU AI Act will layer additional obligations on top for high-risk AI systems in credit scoring and insurance.
For a detailed breakdown of the standards that underpin these deliverables, ISO 42001, SOC 2, and NIST: AI Governance Standards MSPs Must Deliver covers how each framework maps to client requirements.
AI Governance in Healthcare: HIPAA, Patient Data, and Clinical AI Controls
AI governance healthcare engagements center on two distinct risk categories: data privacy risk and clinical risk. Both require controls that go beyond what a standard IT governance framework provides.
- HIPAA and AI governance customer data. Any AI system that processes, transmits, or stores protected health information (PHI) is subject to HIPAA’s Privacy Rule and Security Rule. This includes training data, inference inputs, model outputs, and audit logs — all of which may contain PHI. MSPs scoping healthcare AI governance engagements need to conduct a HIPAA-scoped data mapping exercise that identifies where PHI enters and exits AI workflows, and implement controls accordingly: encryption at rest and in transit, access controls, minimum necessary standards for data use, and business associate agreement (BAA) coverage for any third-party AI vendors.
AI governance data privacy in healthcare also intersects with state-level laws. Washington’s My Health MY Data Act, for example, extends privacy protections beyond HIPAA’s scope and applies to consumer health data processed by AI systems. California’s CMIA adds similar requirements. MSPs serving multi-state health systems need to map the applicable state law landscape, not just HIPAA.
- Clinical AI risk. The FDA regulates AI-based software as a medical device (SaMD) when it meets the definition of a device under 21 CFR Part 820. Clinical decision support tools, diagnostic imaging AI, and predictive risk models used in care management may all fall within FDA’s jurisdiction. Even where FDA oversight doesn’t apply directly, health systems face liability exposure for AI-assisted clinical decisions, and their legal and compliance teams will expect governance controls that document model performance, bias testing, and change management.
MSPs positioned as the compliance delivery layer for healthcare clients need to be prepared to produce documentation that satisfies both HIPAA auditors and clinical risk committees. That means governance artifacts — policies, risk assessments, training records, incident response plans — not just technical controls.
AI Governance in the Defense Industrial Base: CMMC, Export Controls, and Sensitive AI Use
AI governance defense industrial base engagements are the most complex of the three verticals, and the most consequential to get wrong. DIB contractors face overlapping obligations from the Cybersecurity Maturity Model Certification (CMMC) program, ITAR (International Traffic in Arms Regulations), EAR (Export Administration Regulations), and DFARS clauses that flow down from prime contractors to subcontractors.
- CMMC and AI systems. CMMC Level 2 requires implementation of all 110 practices from NIST SP 800-171, which covers the protection of Controlled Unclassified Information (CUI). AI systems that process, store, or transmit CUI — including training data, model weights, and inference outputs — are in scope for CMMC. MSPs supporting DIB clients on managed service provider AI governance engagements need to assess whether AI systems touch CUI and, if so, ensure those systems are deployed within CMMC-compliant environments.
- Export controls and AI. ITAR and EAR treat certain technical data as controlled exports. AI models trained on controlled technical data, or capable of generating controlled outputs, may themselves constitute controlled items. This has direct implications for cloud deployment (foreign nationals employed by cloud providers may constitute a deemed export), model sharing, and vendor selection. MSPs need to understand these constraints before recommending any AI platform or deployment architecture to a DIB client.
- Supply-chain AI risk. DIB clients are increasingly required to assess the AI governance posture of their own supply chains. DFARS 252.204-7012 and related clauses impose cybersecurity requirements that flow to subcontractors, and the DoD’s AI and Data Acceleration initiative is pushing AI governance requirements further down the supply chain. A consultancy AI governance service that helps prime contractors assess and document subcontractor AI risk is a service few MSPs currently offer in this market.
Building a Cross-Vertical AI Governance Service That Scales Across All Three Sectors
The challenge for MSPs and consultancies is that each vertical has distinct requirements, but rebuilding your delivery model from scratch for every engagement is not a viable business. A layered service architecture solves this: a common governance core with vertical-specific modules that activate based on client industry.
- The common core covers the elements that apply across all three sectors: AI system inventory, risk classification, policy framework, audit trail infrastructure, vendor assessment, and incident response. ISO 42001 and NIST AI RMF provide the structural layer here — not as compliance programs in themselves, but as the governance skeleton on which sector-specific controls are built. AI governance GDPR compliance controls also belong in the core for any client with EU data subjects, regardless of industry.
- Vertical modules activate on top of the core based on the client’s regulatory environment:
- Financial services module: SR 11-7 model risk management controls, explainability documentation, adverse action notice support, regulatory examination readiness.
- Healthcare module: HIPAA data mapping, BAA management, clinical AI risk assessment, FDA SaMD scoping, state health privacy law mapping.
- Defense module: CMMC scoping for AI systems, CUI data flow mapping, export control assessment, supply-chain AI risk documentation.
This architecture lets a managed service provider AI governance practice price and scope engagements efficiently. The core is a fixed deliverable with predictable effort; the vertical modules add scope based on the client’s regulatory footprint, which gives you a clear rationale for pricing the vertical modules separately. For MSPs evaluating how to structure this as a recurring revenue offering rather than a project-based engagement, AI Compliance as a Service: How MSPs and Consultancies Can Build a Recurring Revenue Offering covers the packaging and pricing mechanics in detail. The EU AI Act’s phased implementation schedule is already creating examination pressure for financial services and healthcare clients with EU operations. CMMC’s rollout continues to expand the DIB contractor population subject to certification requirements. MSPs that build vertical fluency now are the ones clients call when the compliance deadline arrives — not the ones they find six months after the fact. For a complete view of how these sector-specific requirements fit within the broader managed service provider AI governance opportunity, the pillar resource AI Governance for Managed Service Providers and Consultancies covers the full strategic and operational picture. You should also review EU AI Act Compliance for MSPs: What Managed Service Providers Need to Know before scoping any engagement for clients with EU operations — the Act’s high-risk AI system classifications cut across all three verticals covered here.
- Ready to scope a vertical-specific AI governance engagement? If you’re an MSP or consultancy building out a regulated-industry AI governance practice, we’d like to talk through how a structured partner program can accelerate your delivery capability. Book a discovery call to discuss your client pipeline and what a white-label or reseller arrangement could look like for your practice.